Publications
65
Citations
717
Est. group size
~18
Recurring co-author estimate
Active years
19
Publishing since 2007
Daniel Boulter works in radiation oncology and neuro-oncology, focusing on treating brain and spine metastases with radiation therapy. His research includes clinical trials that test ways to reduce cognitive side effects of whole-brain radiotherapy, imaging methods to distinguish tumor progression from treatment effects, and studies on fracture risk after spine radiation treatments. This work combines clinical trial design with imaging analysis and treatment planning aimed at improving outcomes and quality of life for cancer patients with metastatic disease to the brain and spine.
Publication output has grown substantially over the last decade, rising from a handful of papers per year in 2017-2019 to a peak of 12 in 2025, though with some year-to-year fluctuation (e.g., a dip in 2024).
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Radiomics and Radiogenomics in Differentiating Progression, Pseudoprogression, and Radiation Necrosis in Gliomas
Biomedicines · 2025
- Expanded analysis of vertebral endplate disruption and its impact on vertebral compression fracture risk
Radiation Oncology · 2025
- Expanded Analysis of Vertebral Endplate Disruption and Its Impact on Vertebral Compression Fracture Risk
Research Square · 2025
- Effect of early integrated neuropsychological care in patients with brain metastases: A phase 2 randomized controlled trial (ATHENA trial).
Journal of Clinical Oncology · 2025
- Initial report of memory avoidance whole brain radiotherapy to treat brain metastases: A prospective phase 2 trial.
Journal of Clinical Oncology · 2025
- RDTA-06 AN INITIAL REPORT OF MEMORY AVOIDANCE WHOLE BRAIN RADIOTHERAPY TO TREAT BRAIN METASTASES: A PROSPECTIVE PHASE 2 TRIAL
Neuro-Oncology Advances · 2025
- CTLT-02 EFFECT OF EARLY INTEGRATED NEUROPSYCHOLOGICAL CARE IN PATIENTS WITH BRAIN METASTASES – A PHASE 2 RANDOMIZED CONTROLLED TRIAL (ATHENA TRIAL)
Neuro-Oncology Advances · 2025
- An Initial Report of Memory Avoidance Whole Brain Radiotherapy to Treat Brain Metastases: A Prospective Phase 2 Trial
International Journal of Radiation Oncology*Biology*Physics · 2025
- Effect of Early Integrated Neuropsychological Care in Patients with Brain Metastases: A Phase 2 Randomized Controlled Trial (ATHENA Trial)
International Journal of Radiation Oncology*Biology*Physics · 2025
- Baseline and Time-Dependent Predictors of Cognitive Decline for Brain Metastasis Patients Treated with Radiotherapy– A Secondary Analysis of the ATHENA Trial
International Journal of Radiation Oncology*Biology*Physics · 2025
- NCOG-16. Effect of Early Integrated Neuropsychological Care in Patients with Brain Metastases – A Phase 2 Randomized Controlled Trial (ATHENA Trial)
Neuro-Oncology · 2025
- RADT-32. AN INITIAL REPORT OF MEMORY AVOIDANCE WHOLE BRAIN RADIOTHERAPY TO TREAT BRAIN METASTASES: A PROSPECTIVE PHASE 2 TRIAL
Neuro-Oncology · 2025
- ACR Appropriateness Criteria® Thoracic Back Pain
Journal of the American College of Radiology · 2024
- ACR Appropriateness Criteria® Imaging of Suspected Intracranial Hypotension
Journal of the American College of Radiology · 2024
- A Prospective Registry Study of 68Ga-DOTATATE PET/CT Incorporation Into Treatment Planning of Intracranial Meningiomas
International Journal of Radiation Oncology*Biology*Physics · 2023
- International Journal of Radiation Oncology*Biology*Physics×12
- Journal of the American College of Radiology×7
- Neurosurgery×4
- Neuro-Oncology×4
- Neuro-Oncology Advances×4
- Raj Singh
Medicine · The Ohio State University
- Raju R. Raval
Medicine · The Ohio State University
- Rituraj Upadhyay
Medicine · The Ohio State University
- Sasha Beyer
Medicine · The Ohio State University
- John McGregor
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile